Literature DB >> 34636884

Combination lipid-lowering therapy as first-line strategy in very high-risk patients.

Kausik K Ray1, Laurens F Reeskamp2, Ulrich Laufs3, Maciej Banach4, François Mach5, Lale S Tokgözoğlu6, Derek L Connolly7, Anja J Gerrits8, Erik S G Stroes2, Luis Masana9, John J P Kastelein2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 34636884     DOI： 10.1093/eurheartj/ehab718

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  6 in total

1.  The Egyptian Association of Vascular Biology and Atherosclerosis (EAVA) Perspectives on the Usage of Inclisiran.

Authors:  Ahmed Shawky Elserafy; Ahmed Bendary; Atef Elbahry; Elsayed Farag; Tamer Mostafa; Osama Sanad; Ahmed Elkersh; Mohammed Selim; Hany Ragy; Hazem Khamis; Waleed Abdo; Ashraf Reda
Journal:  Cardiol Ther       Date:  2022-09-02

2.  Post-discharge and long-term follow-up after an acute coronary syndrome: International Collaborative Group of CNCF position paper.

Authors:  Pierre Sabouret; Gilles Lemesle; Anne Bellemain-Appaix; Pierre Aubry; Pier-Paolo Bocchino; Erik Rafflenbeul; Loïc Belle; Jim Nolan; Marco Bernardi; Giuseppe Biondi-Zoccai; Michael P Savage; Maciej Banach; Guillaume Cayla
Journal:  Arch Med Sci       Date:  2022-06-23       Impact factor: 3.707

3.  Trends in Ezetimibe Prescriptions as Monotherapy or Fixed-Dose Combination in Germany 2012-2021.

Authors:  Julius L Katzmann; Marita Kieble; Salka Enners; Michael Böhm; Felix Mahfoud; Ulrich Laufs; Martin Schulz
Journal:  Front Cardiovasc Med       Date:  2022-06-13

4.  Which patients at risk of cardiovascular disease might benefit the most from inclisiran? Polish experts' opinion. The compromise between EBM and possibilities in healthcare.

Authors:  Maciej Banach; Jarosław Kaźmierczak; Przemysław Mitkowski; Krystian Wita; Marlena Broncel; Mariusz Gąsior; Marek Gierlotka; Robert Gil; Piotr Jankowski; Maciej Niewada; Adam Witkowski
Journal:  Arch Med Sci       Date:  2022-03-17       Impact factor: 3.707

5.  Interventional Cardiology: Current Challenges in Acute Myocardial Infarction.

Authors:  Andreas Schäfer
Journal:  J Clin Med       Date:  2022-08-02       Impact factor: 4.964

Review 6.  Bempedoic Acid: for Whom and When.

Authors:  Massimiliano Ruscica; Cesare R Sirtori; Stefano Carugo; Maciej Banach; Alberto Corsini
Journal:  Curr Atheroscler Rep       Date:  2022-07-28       Impact factor: 5.967
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.